12 cases of brain disease after vaccines

October 24, 2006

The U.S. Food and Drug Administration said 12 cases of a neurological disorder have been reported following the application of a meningococcal vaccine.

The FDA said the 12 cases of Guillain-Barre Syndrome have been reported after administering of the vaccines, which are manufactured by French company Sanofi Pasteur, since October 2005, The Wall Street Journal reported Tuesday.

However, the FDA said sufficient evidence was not available to tie the vaccine to the disease and patients should continue to use it if instructed by their doctors.

The vaccines are used to prevent meningococcal disease, which causes bacterial meningitis -- an infection that attacks the lining of the brain and spinal cord. The disease affects about 1-in-100,000 young people every year.

Copyright 2006 by United Press International

Explore further: Chronic wasting disease containment demands vigilance, common sense

Related Stories

Ex-Iowa State scientist gets prison for faking HIV research

July 1, 2015

A former Iowa State University scientist who altered blood samples to make it appear he had achieved a breakthrough toward a potential vaccine against HIV was sentenced Wednesday to more than 4 ½ years in prison for making ...

Recommended for you

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

Quantum Theory May Explain Wishful Thinking

April 14, 2009

(PhysOrg.com) -- Humans don’t always make the most rational decisions. As studies have shown, even when logic and reasoning point in one direction, sometimes we chose the opposite route, motivated by personal bias or simply ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.